Literature DB >> 16517888

Genotype 1 and genotype 2 bovine noroviruses are antigenically distinct but share a cross-reactive epitope with human noroviruses.

S L Oliver1, C A Batten, Y Deng, M Elschner, P Otto, A Charpilienne, I N Clarke, J C Bridger, P R Lambden.   

Abstract

The bovine enteric caliciviruses Bo/Jena/1980/DE and Bo/Newbury2/1976/UK represent two distinct genotypes within a new genogroup, genogroup III, in the genus Norovirus of the family Caliciviridae. In the present study, the antigenic relatedness of these two genotypes was determined for the first time to enable the development of tests to detect and differentiate between both genotypes. Two approaches were used. First, cross-reactivity was examined by enzyme-linked immunosorbent assay (ELISA) using recombinant virus-like particles (VLPs) and convalescent-phase sera from calves infected with either Jena (genotype 1) or Newbury2 (genotype 2). Second, cross-reactivity was examined between the two genotypes with a monoclonal antibody, CM39, derived using Jena VLPs. The two genotypes, Jena and Newbury2, were antigenically distinct with little or no cross-reactivity by ELISA to the heterologous VLPs using convalescent calf sera that had homologous immunoglobulin G titers of log10 3.1 to 3.3. CM39 reacted with both Jena and heterologous Newbury2 VLPs. The CM39 epitope was mapped to nine amino acids (31PTAGAQIAA39) in the Jena capsid protein, which was not fully conserved for Newbury2 (31PTAGAPVAA39). Molecular modeling showed that the CM39 epitope was located within the NH2-terminal arm inside the virus capsid. Surprisingly, CM39 also reacted with VLPs from two genogroup II/3 human noroviruses by ELISA and Western blotting. Thus, although the bovine noroviruses Jena and Newbury2 corresponded to two distinct antigenic types or serotypes, they shared at least one cross-reactive epitope. These findings have relevance for epidemiological studies to determine the prevalence of bovine norovirus serotypes and to develop vaccines to bovine noroviruses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517888      PMCID: PMC1393167          DOI: 10.1128/JCM.44.3.992-998.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  40 in total

1.  Evaluation of a latex agglutination kit (Virogen Rotatest) for detection of bovine rotavirus in fecal samples.

Authors:  Y Al-Yousif; J Anderson; C Chard-Bergstrom; A Bustamante; M Muenzenberger; K Austin; S Kapil
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

Review 2.  Genetic classification of "Norwalk-like viruses..

Authors:  T Ando; J S Noel; R L Fankhauser
Journal:  J Infect Dis       Date:  2000-05       Impact factor: 5.226

3.  Characterization of capsid genes, expressed in the baculovirus system, of three new genetically distinct strains of "Norwalk-like viruses".

Authors:  G Belliot; J S Noel; J F Li; Y Seto; C D Humphrey; T Ando; R I Glass; S S Monroe
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

4.  Characterization of monoclonal antibodies generated against Norwalk virus GII capsid protein expressed in Escherichia coli.

Authors:  T Yoda; Y Terano; Y Suzuki; K Yamazaki; I Oishi; E Utagawa; A Shimada; S Matsuura; M Nakajima; T Shibata
Journal:  Microbiol Immunol       Date:  2000       Impact factor: 1.955

5.  Baculovirus expression and antigenic characterization of the capsid proteins of three Norwalk-like viruses.

Authors:  X Jiang; W M Zhong; T Farkas; P W Huang; N Wilton; E Barrett; D Fulton; R Morrow; D O Matson
Journal:  Arch Virol       Date:  2002       Impact factor: 2.574

6.  Studies of epidemiology and seroprevalence of bovine noroviruses in Germany.

Authors:  Y Deng; C A Batten; B L Liu; P R Lambden; M Elschner; H Günther; P Otto; P Schnürch; W Eichhorn; W Herbst; I N Clarke
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

7.  Reverse transcription-PCR assays for detection of bovine enteric caliciviruses (BEC) and analysis of the genetic relationships among BEC and human caliciviruses.

Authors:  J R Smiley; A E Hoet; M Tråvén; H Tsunemitsu; L J Saif
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

8.  Norwalk-like calicivirus genes in farm animals.

Authors:  W H van Der Poel; J Vinjé; R van Der Heide; M I Herrera; A Vivo; M P Koopmans
Journal:  Emerg Infect Dis       Date:  2000 Jan-Feb       Impact factor: 6.883

9.  Cross-reactivity among several recombinant calicivirus virus-like particles (VLPs) with monoclonal antibodies obtained from mice immunized orally with one type of VLP.

Authors:  Noritoshi Kitamoto; Tomoyuki Tanaka; Katsurou Natori; Naokazu Takeda; Shuji Nakata; Xi Jiang; Mary K Estes
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

10.  Characterisation of the bovine enteric calici-like virus, Newbury agent 1.

Authors:  A M Dastjerdi; D R Snodgrass; J C Bridger
Journal:  FEMS Microbiol Lett       Date:  2000-11-01       Impact factor: 2.742

View more
  24 in total

1.  Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.

Authors:  Gabriel I Parra; Eugenio J Abente; Carlos Sandoval-Jaime; Stanislav V Sosnovtsev; Karin Bok; Kim Y Green
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  Characterization of a broadly reactive monoclonal antibody against norovirus genogroups I and II: recognition of a novel conformational epitope.

Authors:  Tomoyuki Shiota; Michio Okame; Sayaka Takanashi; Pattara Khamrin; Makiko Takagi; Kenji Satou; Yuichi Masuoka; Fumihiro Yagyu; Yuko Shimizu; Hideki Kohno; Masashi Mizuguchi; Shoko Okitsu; Hiroshi Ushijima
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

3.  Infection of calves with bovine norovirus GIII.1 strain Jena virus: an experimental model to study the pathogenesis of norovirus infection.

Authors:  Peter H Otto; Ian N Clarke; Paul R Lambden; Omar Salim; Jochen Reetz; Elisabeth M Liebler-Tenorio
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

4.  Prevalence of recovirus-neutralizing antibodies in human serum samples.

Authors:  Tibor Farkas; Cindy Wong Ping Lun
Journal:  J Clin Microbiol       Date:  2014-06-04       Impact factor: 5.948

5.  Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.

Authors:  Jackie E Mahar; Nicole C Donker; Karin Bok; Gert H Talbo; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

6.  Genetic heterogeneity of porcine enteric caliciviruses identified from diarrhoeic piglets.

Authors:  V Martella; K Bányai; E Lorusso; A L Bellacicco; N Decaro; V Mari; L Saif; V Costantini; S De Grazia; G Pezzotti; A Lavazza; C Buonavoglia
Journal:  Virus Genes       Date:  2008-01-19       Impact factor: 2.332

7.  Exposure to human and bovine noroviruses in a birth cohort in southern India from 2002 to 2006.

Authors:  Vipin Kumar Menon; Santosh George; Aruna A Shanti; Anuradha Saravanabavan; Prasanna Samuel; Sasirekha Ramani; Mary K Estes; Gagandeep Kang
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

8.  Serotype 1 and 2 bovine noroviruses are endemic in cattle in the United kingdom and Germany.

Authors:  S L Oliver; E Wood; E Asobayire; D C Wathes; J S Brickell; M Elschner; P Otto; P R Lambden; I N Clarke; J C Bridger
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

9.  Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II.

Authors:  Horacio Almanza; Carolina Cubillos; Iván Angulo; Francisco Mateos; José R Castón; Wim H M van der Poel; Jan Vinje; Juan Bárcena; Ignacio Mena
Journal:  J Clin Microbiol       Date:  2008-10-08       Impact factor: 5.948

10.  The alphaGal epitope of the histo-blood group antigen family is a ligand for bovine norovirus Newbury2 expected to prevent cross-species transmission.

Authors:  Maha Zakhour; Nathalie Ruvoën-Clouet; Annie Charpilienne; Brigitte Langpap; Didier Poncet; Thomas Peters; Nicolai Bovin; Jacques Le Pendu
Journal:  PLoS Pathog       Date:  2009-07-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.